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Abstract
Cardiovascular implantable electronic devices (CIEDs) are fre-
quently related to endocarditis. Most cases of intravascular CIED
infections are usually related to skin ﬂora, but a few cases may
occur with negative blood culture. Coxiella burnetii is one of the
main causes of blood culture-negative endocarditis in native and
prosthetic valves, but to date no cases related to CIED have
been published. Herein we report two cases of Q fever endo-
carditis related to these non-valvular cardiovascular devices.
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Indications for cardiovascular implantable electronic devices
(CIEDs) such as permanent pacemakers (PPMs) and
implantable cardioverter-deﬁbrillators (ICDs) have increased
in the last decades. Infections of these electronic devices
have been recognized as important challenges in clinical
practice since 1971 [1]. Although most infections are lim-
ited to the pocket, involvement of intravascular wires
accounts for approximately 10% of cases, with high morbid-
ity and mortality [2]. Staphylococcal species are the main
cause of CIED infections, representing 60–80% of cases in
most series. However, in 8% of events there is not a caus-
ative agent [3]. Coxiella burnetii is one of the most impor-
tant microorganisms implicated in blood culture-negative
endocarditis in our geographical area [4,5] but to our
knowledge, no cases of PPM or ICD-related endocarditis
have been published. Herein we report two cases of CIED




A 51-year-old man with a bicameral ICD developed intermit-
tent fever, purpuric skin lesions in the legs, bone pain and
wrist arthritis 4 years after its implantation. Blood cultures
were positive for Brucella melitensis and seroagglutination
showed titres of 5210. The patient was treated with strepto-
mycin (21 days) plus doxycycline (45 days). The outcome
was initially favourable, but 4 months later he developed sim-
ilar symptoms. Relapse was considered and a similar treat-
ment was started. He also had a favourable course but
developed the same clinical picture 6 months later. Then he
was treated again for Brucella infection and completely recov-
ered. On this occasion blood cultures were negative. Five
months later the patient was again symptomatic, and indirect
immunoﬂuorescence assays (IFAs) against C. burnetii showed
IgG titres of 1024 (phases I and II) (Focus Diagnostics,
Cypress, CA, USA). A transoesophageal echocardiography
(TEE) showed vegetations on the pacemaker wires. Doxycy-
cline plus ciproﬂoxacin were prescribed. The device was
completely removed by percutaneous traction. DNA was
extracted from the vegetations using the QIAmp DNA Tis-
sue minikit (Quiagen, Hilden, Germany). Polymerase chain
reaction (PCR) methods targeting the htp-AB gene for C. bur-
netii, and 16S rRNA, 31-kDa protein and omp-2 genes for
Brucella spp. were positive. PCR primers and size of ampli-
cons are shown in Table 1. Negative controls (with template
DNA but without primers and with primers and containing
water instead of DNA) were included.
Nucleotide sequence analysis showed 100% identity with
htp-AB from C. burnetii and with 16S rRNA, 31-kDa protein
and omp-2 genes from Brucella melitensis, respectively.
Sequences for htp-AB and 16S rRNA generated in this study
were deposited in GenBank under accession numbers
JX275487 and JX275486, respectively. Specimens were also
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analysed by IS30a quantitative PCR (qPCR) using a 7300 Real
Time PCR system (Applied Biosystems, Foster City, CA,
USA), according to Brouqui et al. (2005) with slight modiﬁca-
tions [11]. Primers and probe are shown in Table 2. The
PCR mixture contained 10 lL of Premix Ex Taq (Probe
qPCR) (Takara), 0.4 lL (10 lM) of each primer, 0.4 lL
(10 lM) of a double-quenched hydrolysis probe (Integrated
DNA Technologies, Coralville, IA, USA), 0.4 lL ROX refer-
ence dye, 3.4 lL of distilled water, and 5 lL of DNA. Using
this technique, the sample was positive with a cycle thresh-
old value of 32.8. Culture in cells was not undertaken. A
new device was implanted 1 month later. The patient com-
pleted 12 months of treatment and, 1 year after the cessa-
tion of antimicrobial therapy, remains asymptomatic.
Case 2
A 74-year-old man with a PPM was admitted for fever, mal-
aise, anorexia, weight loss and cough during the last month.
Before admission he had been treated at home with amoxi-
cillin and then ciproﬂoxacin, without improvement. A chest
X-ray and a computed tomography (CT) scan showed multi-
ple cavitated nodules in both lungs. A TEE was made and
vegetations on the tricuspid valve and wires were identiﬁed.
Repeated blood cultures were negative. Staphylococcal infec-
tion was suspected and daptomycin plus gentamycin were
administered. Ten days later, the device was extracted by
right auriculotomy. PCR assays for C. burnetii intergenic
spacer IS1111 from vegetations were performed as previ-
ously described (Table 1), yielding positive results. Sequenc-
ing conﬁrmed highest identity (99.4%) with C. burnetii
(GenBank accession no. JX275488). This sample was positive
with a cycle threshold value of 34.2 using IS30a qPCR. IFA
showed IgG titres of 1600 (phases I and II). Culture in cells
was not undertaken. Doxycyclin and chloroquine were
administered and the patient, still on treatment, is now
asymptomatic.
Discussion
In the last years CIED endocarditis has been recognized as an
important problem in clinical practice. As occurs for endocar-
ditis on native or prosthetic valves, implicated microorgan-
isms are not always recognized. Although few infections are
due to microorganisms coming from a remote source that
shed on wires, contamination from skin ﬂora during surgery
is the main mechanism for development of infection on these
devices. Therefore, Staphylococcus spp. are the most frequent
microorganisms involved [3]. When blood cultures are nega-
tive, empirical treatment is usually given for this aetiology.
C. burnetti and Bartonella spp. are the main bacteria implicated
in endocarditis with negative blood culture in Europe, with
important series published in France and Spain [4,5,12].
Recently, a large outbreak has been described in the Nether-
lands and, from 2007 to 2009, 3.1% of 3264 cases of acute Q
fever developed endocarditis [13]. However, no Q fever
infections on CIEDs have been reported. In our ﬁrst case,
molecular biological tools also demonstrated chronic infec-
tion by B. melitensis. Brucella endocarditis is a rare and life
threatening complication of brucellosis. Only seven cases on
CIEDs have been reported [14]. Our patient had three
relapses despite appropriate treatment. Co-infection with
C. burnetii could have been the cause because this agent usu-
ally requires 12–24 months of treatment [3,4]. Doxycycline
TABLE 1. PCR primer pairs used for conventional PCR methods in this study
Bacteria genus Target gene Primer name Primer sequence (5¢ ﬁ 3¢) Ampliﬁed fragment (bp) Reference
Coxiella htp-AB CB-1
CB-2
ACT CAA CGC ACT GGA ACC GC




TAT GTA TCC ACC GTA GCC AGT C
CCC AAC AAC ACC TCC TTA TTC
687 [7]
Brucella 16S rRNA F4
R2
TCG AGC GCC CGC AAG GGG




TGG CTC GGT TGC CAA TAT CAA




GCG CTC AGG CTG CCG ACG CAA
ACC AGC CAT TGC GGT CGG TA
193 [10]






probe name Primer and probe sequence (5¢ ﬁ 3¢)
Ampliﬁed
fragment (bp) Reference
Coxiella IS30a Cbis30aF AAT GTC TGC GGG AAA TAG GC 120 [11]
Cbis30aR GAG GCC TTT TAC CGG AAT TC
IS30a 6FAM-TCG AGA TCA-ZEN-TAG CGT CAT T-IABkFQ
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and hydroxychloroquine were not prescribed in order to
avoid photosensitivity problems, because the patient works
outdoors in a sunny area of southern Spain. Surgical removal
of the device and accurate diagnosis were essential to achieve
the cure. We think that molecular biological techniques may
be an important aid also in this setting, as has been demon-
strated for blood culture-negative endocarditis [15].
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